Insider Transactions in Q3 2024 at Contineum Therapeutics, Inc. (CTNM)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 13
2024
|
Stephen L. Huhn CMO & Sr VP, Clinical Dev. |
BUY
Exercise of conversion of derivative security
|
Direct |
12,800
+50.0%
|
$12,800
$1.01 P/Share
|